UPC APP 36985/2025

—·EP2377536: Methods of Using Sustained Release Aminopyridine Compositions

Verfahrensdetails: Status
—
Verfahrensart
Verfahrensantrag
Kategorie
Sonstige prozessuale
Parteien: Kläger
Merz Therapeutics GmbH
Merz Pharmaceuticals LLC
Merz Pharma France
Vertreter: Laëtitia Bénard
Beklagte
Viatris Santé
Vertreter: Marc Lauzeral
Division: Paris LD
Richter: Camille Lignieres · Presiding judge and judge-rapporteur
Carine Gillet · Legally qualified judge
Samuel Granata · Legally qualified judge
Rainer Friedrich · Technically qualified judge
Technology: Pharmaceutical & Medical
Sprache: —
Erste Entscheidung: 17. Sept. 2025

Entscheidungen

2025-09-17
Generic application
Paris Local Division order (judge-rapporteur Lignières, full panel) in provisional measures proceedings by Merz Therapeutics GmbH and related Merz entities against Viatris Santé concerning EP 2 377 536 (botulinum toxin / SPC FR13C0033). The order addresses Merz's procedural application (R. 9 RoP) to limit or restructure Viatris' 473-page objection, or alternatively to set a page limit for subsequent submissions. No substantive ruling on the provisional measures application.
Rechtsfragen:Provisional measures procedural application (R. 9 RoP)Page limit for pleadingsBotulinum toxin / SPC patent

Dokumente